GlaxoSmithKline CR`s EBIT Growth reached 66.2 % in 2017. This is 215 % less than in the previous year.
Buy EBIT Growth data for GlaxoSmithKline Czech Republic.
$19.99Buy all data for GlaxoSmithKline Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | % | ... | ... | ... | ... | ... | 56.9 | -37.9 | 11.3 | 34.9 | -15.5 | |||||||
| Bayer Czech Republic | % | ... | ... | ... | 6.82 | -34.6 | 22.5 | 8.75 | 17.7 | |||||||||
| GlaxoSmithKline Czech Republic | % | ... | ... | ... | 31.9 | -25.9 | -21.8 | -29.3 | 6.70 | |||||||||
| Merck Czech Republic | % | ... | ... | 182 | 25.3 | -41.6 | 9.10 | 80.1 | ||||||||||
| Novartis Czech Republic | % | 1.78 | 12.9 | -2.41 | 56.3 | 13.5 | ||||||||||||
| Pfizer Czech Republic | % | ... | ... | 114 | -79.1 | 169 | -0.115 | -42.2 | ||||||||||
| Roche Czech Republic | % | ... | ... | ... | -39.8 | -16.9 | 165 | -26.8 | -39.3 | ... | ||||||||
| Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | 29.9 | -13.9 | 25.2 | -88.8 | 796 | ||||||||
| Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 4.17 | 0.879 | 11.5 | ||
| Walmark | % | ... | ... | ... | 34.0 | -77.4 | -40.2 | 207 | -413 |
Helgi Library 
